Skip to main content
Premium Trial:

Request an Annual Quote

Transgenomic Names New CEO Three Months After D’Silva Resigns

NEW YORK (GenomeWeb News) - Transgenomic has named Craig Tuttle president and CEO, effective immediately.
 
Tuttle replaces Collin D'Silva, who resigned in April. Michael Summers, the company's chief financial officer, served as interim CEO. He will remain CFO, Transgenomic said. D'Silva now chairs Transgenomic's board.
 
Tuttle formerly served as president and chief operating officer of Duke Scientific, a specialty chemistry manufacturer. Prior to that he was the president of Applied Biotech, a home pregnancy test manufacturer.
 
Tuttle has also held management positions with Boehringer Mannheim, Bayer Healthcare, and Cetus. He holds a BSc in biochemistry from the University of California, Los Angeles, an MSc in biochemistry from the University of Colorado, and an MBA from St. Mary's College.

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.